Clearside Biomedical | 8-K:重大事件
Clearside Biomedical | 10-Q:2024财年二季报
Clearside Biomedical | 8-K:Clearside Biomedical公布2024年第二季度财务业绩并提供公司最新情况
Clearside Biomedical | 8-K:重大事件
Clearside Biomedical | 3/A:首次持股声明(修正)-高管 Chong Ngai Hang Victor
Clearside Biomedical | 4:持股变动声明-高管 Chong Ngai Hang Victor
Clearside Biomedical | 4:持股变动声明-董事 SHAFFER CHRISTY L
Clearside Biomedical | 4:持股变动声明-董事 Thorp Clay
Clearside Biomedical | 4:持股变动声明-董事 Humphries William D.
Clearside Biomedical | 4:持股变动声明-董事 EDWARDS JEFFREY L
Clearside Biomedical | 4:持股变动声明-董事 Croarkin Richard
Clearside Biomedical | 4:持股变动声明-董事 Hutson Nancy J
Clearside Biomedical | 4:持股变动声明-董事 YERXA BENJAMIN R
Clearside Biomedical | 4:持股变动声明-董事 Gibney Anthony S
Clearside Biomedical | 8-K:重大事件
Clearside Biomedical | 4:持股变动声明-董事 YERXA BENJAMIN R
Clearside Biomedical | S-8:员工福利计划证券登记
Clearside Biomedical | 10-Q:2024财年一季报
Clearside Biomedical | 8-K:Clearside Biomedical公布2024年第一季度财务业绩并提供公司最新情况
Clearside Biomedical | ARS:年度报告
暂无数据
暂无数据